Andrey A Poloznikov, Sergey V Nikulin, Arpenik A Zakhariants, Anna Yu Khristichenko, Dmitry M Hushpulian, Ildar N Gazizov, Vladimir I Tishkov, Irina G Gazaryan
BACKGROUND: "Branched tail" oxyquinolines, and adaptaquin in particular, are potent HIF prolyl hydroxylase inhibitors showing promising results in in vivo hemorrhagic stroke models. The further improvement of the potency resulted in identification of a number of adaptaquin analogs. Early evaluation of toxicity and metabolism is desired right at the step of lead selection. OBJECTIVES: The aim of the study is to characterize the toxicity and metabolism of adaptaquin and its new improved analogs...
November 28, 2018: Drug Metabolism Letters